BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher
BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.
Founded in 1997, Labochema is a provider of integrated laboratory solutions, with branches in all three Baltic countries. It also controls Gidela, a fast-growing laboratory furniture company. The companies employ more than 50 people. The company had US$15.1 million revenues in 2020.
Dutscher is one of the leading European laboratory supply distributors, with annual revenues of US$365 million and 700 employees in nine countries. Since 2020, the company is owned by private equity fund manager LBO France (with US$7.3 billion assets under management) and the management team, led by Dominique Wencker. Based in France, Dutscher has experienced strong organic growth complemented by targeted acquisitions in France, Spain, Italy and the UK.
Oaklins’ team in Lithuania acted as a full-scope M&A advisor to the sellers through all stages of the process.
Talk to the deal team
Ricotto has been acquired by Sitra Group
Ricotto S.r.l. has joint Sitra Group, a Belgium-based and PE-backed international logistic and transportation group.Learn more
M80 Partners has acquired Luminis
Belgian private equity fund M80 has acquired a majority stake in Luminis. M80 offers to software and technology company Luminis the opportunity to further expand its strategy and market position internationally. Luminis becomes part of a platform that also includes XPLUS, a Belgian expert in enterprise IT architecture. M80 plans to make further selective acquisitions in Europe in the coming months with the aim of bringing together a portfolio of best-in-class digital transformation specialists.Learn more
Spice Private Equity Ltd. has had a fairness opinion conducted on a public tender offer by GP Investments
On 14 July 2022, GP Swiss Ltd., a subsidiary of GP Investments, published a public tender offer for all publicly held registered shares of Spice Private Equity Ltd. (Spice). The independent members of the Board of Directors of Spice have had a fairness opinion conducted on the financial adequacy of this public tender offer. The offer price for each Spice share was US$16.25 net in cash. Following a successful offer, GP Investment intends to delist the stock from the SIX Swiss Stock Exchange.Learn more